427 related articles for article (PubMed ID: 23922928)
1. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo.
Webber BR; Iacovino M; Choi SH; Tolar J; Kyba M; Blazar BR
Blood; 2013 Oct; 122(17):2978-86. PubMed ID: 24030384
[TBL] [Abstract][Full Text] [Related]
3. Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.
Goardon N; Schuh A; Hajar I; Ma X; Jouault H; Dzierzak E; Roméo PH; Maouche-Chrétien L
Blood; 2002 Jul; 100(2):491-500. PubMed ID: 12091340
[TBL] [Abstract][Full Text] [Related]
4. Effect of endoglin overexpression during embryoid body development.
Baik J; Borges L; Magli A; Thatava T; Perlingeiro RC
Exp Hematol; 2012 Oct; 40(10):837-46. PubMed ID: 22728030
[TBL] [Abstract][Full Text] [Related]
5. SCL/tal-1-dependent process determines a competence to select the definitive hematopoietic lineage prior to endothelial differentiation.
Endoh M; Ogawa M; Orkin S; Nishikawa S
EMBO J; 2002 Dec; 21(24):6700-8. PubMed ID: 12485991
[TBL] [Abstract][Full Text] [Related]
6. MiR-24 is required for hematopoietic differentiation of mouse embryonic stem cells.
Roy L; Bikorimana E; Lapid D; Choi H; Nguyen T; Dahl R
PLoS Genet; 2015 Jan; 11(1):e1004959. PubMed ID: 25634354
[TBL] [Abstract][Full Text] [Related]
7. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
[TBL] [Abstract][Full Text] [Related]
8. Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4.
Kong KY; Williamson EA; Rogers JH; Tran T; Hromas R; Dahl R
Blood; 2009 Jul; 114(1):60-3. PubMed ID: 19321862
[TBL] [Abstract][Full Text] [Related]
9. Regulation of hemangioblast development.
Lacaud G; Robertson S; Palis J; Kennedy M; Keller G
Ann N Y Acad Sci; 2001 Jun; 938():96-107; discussion 108. PubMed ID: 11458531
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
[TBL] [Abstract][Full Text] [Related]
11. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
12. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
13. Haploinsufficiency of Runx1 results in the acceleration of mesodermal development and hemangioblast specification upon in vitro differentiation of ES cells.
Lacaud G; Kouskoff V; Trumble A; Schwantz S; Keller G
Blood; 2004 Feb; 103(3):886-9. PubMed ID: 14525762
[TBL] [Abstract][Full Text] [Related]
14. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
Miller JD; Stacy T; Liu PP; Speck NA
Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse.
Ou X; Chae HD; Wang RH; Shelley WC; Cooper S; Taylor T; Kim YJ; Deng CX; Yoder MC; Broxmeyer HE
Blood; 2011 Jan; 117(2):440-50. PubMed ID: 20966168
[TBL] [Abstract][Full Text] [Related]
16. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.
Ran D; Shia WJ; Lo MC; Fan JB; Knorr DA; Ferrell PI; Ye Z; Yan M; Cheng L; Kaufman DS; Zhang DE
Blood; 2013 Apr; 121(15):2882-90. PubMed ID: 23372166
[TBL] [Abstract][Full Text] [Related]
17. Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript.
Ghanem LR; Kromer A; Silverman IM; Ji X; Gazzara M; Nguyen N; Aguilar G; Martinelli M; Barash Y; Liebhaber SA
Mol Cell Biol; 2018 Aug; 38(16):. PubMed ID: 29866654
[TBL] [Abstract][Full Text] [Related]
18. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis.
Sroczynska P; Lancrin C; Kouskoff V; Lacaud G
Blood; 2009 Dec; 114(26):5279-89. PubMed ID: 19858498
[TBL] [Abstract][Full Text] [Related]
19. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.
Porcher C; Swat W; Rockwell K; Fujiwara Y; Alt FW; Orkin SH
Cell; 1996 Jul; 86(1):47-57. PubMed ID: 8689686
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo.
Mikkola HK; Fujiwara Y; Schlaeger TM; Traver D; Orkin SH
Blood; 2003 Jan; 101(2):508-16. PubMed ID: 12393529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]